The page is the record's research on the issuer — no analyst, no rating, no view. # Guardian Pharmacy Services, Inc. (NYSE: GRDN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Guardian Pharmacy Services, Inc., listed on NYSE under ticker GRDN. Its ISIN is US40145W1018 and its LEI is not on the record (no GLEIF record with the exact legal name in jurisdiction US-GA). Its security type is Corporate, its segment is not on the record, its sector is 5912 Retail-Drug Stores and Proprietary Stores, and its jurisdiction is United States, Georgia. The issuer is listed and not halted. ## The disclosure read The record holds 84 filings in the window 2025-11-08 to 2026-11-08, across 27 filing days. Filings by type are 52 directors' dealings, 11 results, 10 regulatory filings, 4 prospectuses, 3 AGM/EGM notices, 3 corporate news, and 1 director change. The median gap between filing days is 8.0 days, against a NYSE median of 6.0 days and a sector median of 6 days. The latest filing is dated 2026-11-05 and is of type results, 3 days before the record date. Latency is 3 days, against a NYSE median of 4.0 days and a sector median of 2 days. The NYSE median filing count over the window is 64.0 and the sector median is 44. ## Auditor The auditor of record is Ernst & Young LLP, located in Atlanta, Georgia. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line). The segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag is listed, not halted. ## Orderability The outcome is not determinable because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's own investor-relations page names 5 research houses: Jefferies, Oppenheimer, Raymond James, Stephens and Truist. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The vintage is sealed. Sealed years that hold the issuer are 2021, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 9 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001802255.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/GRDN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1802255/000119312526102172/d16111d10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://investors.guardianpharmacy.com/stock-info/analyst-coverage/default.aspx (coverage) - https://mcp.us-cm-kg.ai/record/NYSE/GRDN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/GRDN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp